By Dr Santosh Rath, Visiting Professor, Institute of Global Health Innovation, Imperial College London
The past three decades have witnessed impressive results in leprosy control through global effort. Early detection of disease through door-to-door survey and treatment by multi-drug therapy (MDT) in domiciliary setting ensured high rates of cure (WHO). The focus was to identify and manage high-risk patients prone to complication likes reactions and peripheral nerve function impairment (NFI).